Market Tracker

05/26 6:53am ET

Mylan NV (NASDAQ:MYL)

39.83
Delayed Data
As of May 25
 +0.65 / +1.66%
Today’s Change
33.60
Today|||52-Week Range
50.40
+4.40%
Year-to-Date

Today’s Trading

Previous close39.18
Today’s open39.20
Day’s range38.95 - 39.85
Volume4,691,769
Average volume (3 months)5,617,843
Market cap$20.7B
Dividend yield--
Data as of 05/25/2017

Growth & Valuation

Earnings growth (last year)-45.88%
Earnings growth (this year)+7.16%
Earnings growth (next 5 years)+8.20%
Revenue growth (last year)+17.44%
P/E ratio17.2
Price/Sales1.79
Price/Book1.86

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-0.70-0.80%
ALXNAlexion Pharmaceutic...-2.58-2.55%
INCYIncyte Corp+0.31+0.22%
VRTXVertex Pharmaceutica...+0.80+0.68%
Data as of 05/25/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)$1.19
Annual revenue (last year)$11.1B
Annual profit (last year)$480.0M
Net profit margin4.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts